| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.25 |
9e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.23 |
9e-06 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.23 |
5e-05 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0002 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
0.001 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |